Inebilizumab Interactions
There are 159 drugs known to interact with inebilizumab, along with 4 disease interactions. Of the total drug interactions, 44 are major, and 115 are moderate.
- View all 159 medications that may interact with inebilizumab
- View inebilizumab disease interactions (4)
Most frequently checked interactions
View interaction reports for inebilizumab and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Ambien (zolpidem)
- Amrix (cyclobenzaprine)
- Andexxa (coagulation factor Xa)
- Banzel (rufinamide)
- Brilinta (ticagrelor)
- Briviact (brivaracetam)
- Celexa (citalopram)
- Concerta (methylphenidate)
- Copaxone (glatiramer)
- Coreg (carvedilol)
- Coumadin (warfarin)
- Cytoxan (cyclophosphamide)
- Daytrana (methylphenidate)
- Eliquis (apixaban)
- Emgality (galcanezumab)
- Firdapse (amifampridine)
- Focalin (dexmethylphenidate)
- Humira (adalimumab)
- Intuniv (guanfacine)
- Jakafi (ruxolitinib)
- Kapvay (clonidine)
- Keytruda (pembrolizumab)
- Klonopin (clonazepam)
- Levophed (norepinephrine)
- Lexapro (escitalopram)
- Librium (chlordiazepoxide)
Inebilizumab disease interactions
There are 4 disease interactions with inebilizumab which include:
Report options
More about inebilizumab
- inebilizumab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Uplizna
Uplizna is used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) or ...
Enspryng
Enspryng is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Bkemv
Bkemv (eculizumab-aeeb) is an interchangeable biosimilar to Soliris which may be used to treat ...
Epysqli
Epysqli (eculizumab-aagh), a biosimilar to Soliris, targets the complement system to treat ...
Satralizumab
Satralizumab (Enspryng) is used to treat adults with neuromyelitis optica spectrum disorder ...
Ravulizumab
Ravulizumab-cwvz is used to treat myasthenia gravis (gMG), hemolytic uremic syndrome (aHUS) ...
Eculizumab
Eculizumab (brand names Soliris, Bkemv, and Epysqli) is used to treat paroxysmal nocturnal ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
